Regeneron Pharmaceuticals, Inc. (0R2M)
Market Open
5 Dec, 10:00
$
723. 57
+0.28
+0.04%
$
- Market Cap
24.52 P/E Ratio
0% Div Yield
3 Volume
42.79 Eps
$ 723.29
Previous Close Day Range
722.11 726.54
Year Range
689 998.57
Want to track 0R2M and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
| 0R2M Regeneron Pharmaceuticals, Inc. 2 Feb 2026 (In 1 month) | | - Cons. EPS | - EPS |
| 0R2M Regeneron Pharmaceuticals, Inc. 29 Oct 2025 | | - Cons. EPS | - EPS |
| 0R2M Regeneron Pharmaceuticals, Inc. 1 Aug 2025 | | - Cons. EPS | - EPS |
0R2M Earnings Reports FAQ
What is the earnings per share (EPS) for 0R2M?
The current EPS is 42.79.
What is the company's earnings growth rate?
Regeneron Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-02, based on the 0R2M's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Regeneron Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0R2M at this time, as Regeneron Pharmaceuticals, Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
